Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Citrate is a safer alternative to heparin for preventing blood clots in hemodialysis.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Indole-based compounds improved ovarian health in rats with PCOS, with L-Tryptophan and Tryptophol being most effective.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Finasteride helps prevent kidney stones, but side effects need more research.

Antiandrogens don't help with COVID-19 and aren't recommended.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Oral contraceptives with CPA improve overall quality of life for women with PCOS.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.